DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Butts CA, Socinski MA, Mitchell P et al.
START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer.
J Clin Oncol 2013;
31 abstr 7500
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.